跳至主導覽
跳至搜尋
跳過主要內容
國立臺灣師範大學 首頁
專家資料申請/更新
連結會在新分頁中打開
English
中文
在 國立臺灣師範大學 搜尋內容
首頁
個人檔案
研究單位
研究成果
研究計畫
新聞/媒體
資料集
學術活動
得獎記錄
學生論文
RETRACTED: Long-Lasting Exendin-4-Loaded PLGA Nanoparticles Ameliorate Cerebral Ischemia/Reperfusion Damage in Diabetic Rats
Cheng Hsun Chung
, Shiu Dong Chung
, Yu Hsuan Cheng
, Chun Pai Yang
*
,
Chiang Ting Chien
*
*
此作品的通信作者
生命科學系
研究成果
:
雜誌貢獻
›
期刊論文
›
同行評審
9
連結會在新分頁中打開
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「RETRACTED: Long-Lasting Exendin-4-Loaded PLGA Nanoparticles Ameliorate Cerebral Ischemia/Reperfusion Damage in Diabetic Rats」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Brain Ischemia
100%
Exenatide
100%
Nanoparticle
100%
Ischemia
83%
Programmed Cell Death
66%
Autophagy
66%
Endoplasmic Reticulum Stress
66%
Cerebrospinal Fluid
66%
Pyroptosis
66%
Hydrogen Peroxide
50%
Diabetes Mellitus
50%
Type 1 Diabetes
50%
Oxidative Stress
33%
Bladder
33%
Micturition
33%
Edema
33%
Antioxidant Capacity
33%
Prefrontal Cortex
33%
Western Blot
16%
Poly ADP Ribose Polymerase
16%
Combination Therapy
16%
Interleukin 1beta Converting Enzyme
16%
Streptozocin
16%
Interleukin 1
16%
Diabetes
16%
Immunohistochemistry
16%
Caspase 12
16%
Beclin 1
16%
Induced Hypotension
16%
Carotid Artery Stenosis
16%
Voiding Dysfunction
16%
Antidiabetic Activity
16%
Bioavailability
16%
Polyglactin
16%
Caspase 3
16%
CHOP
16%
Incretin
16%
Cerebral Ischemia-Reperfusion Injury
16%
INIS
damage
100%
rats
100%
ischemia
100%
nanoparticles
100%
fluids
57%
brain
57%
apoptosis
57%
endoplasmic reticulum
57%
levels
28%
comparative evaluations
28%
antioxidants
28%
injection
28%
oxidation
28%
hypochlorous acid
28%
edema
28%
bladder
28%
data
14%
applications
14%
protection
14%
injuries
14%
hemorrhage
14%
streptozotocin
14%
biological availability
14%
hypotension
14%
carotid arteries
14%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Brain Ischemia
100%
Exendin 4
100%
Ischemia
83%
Pyroptosis
66%
Hydrogen Peroxide
50%
Diabetes Mellitus
50%
Antioxidant Capacity
33%
Edema
33%
Wistar Rat
16%
Streptozotocin
16%
Western Blot
16%
Reperfusion Injury
16%
Interleukin 1beta Converting Enzyme
16%
Interleukin 1
16%
Beclin 1
16%
Caspase 3
16%
Combination Therapy
16%
Hypotension
16%
Incretin
16%
Bioavailability
16%
Carotid Artery Obstruction
16%
Polyglactin
16%
Caspase 12
16%
Antidiabetic Agent
16%